Journal article
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)
Abstract
Authors
Turpie AGG; Bauer KA; Davidson BL; Fisher WD; Gent M; Huo MH; Sinha U; Gretler DD
Journal
Thrombosis and Haemostasis, Vol. 101, No. 01, pp. 68–76
Publisher
Thieme
Publication Date
January 1, 2009
DOI
10.1160/th08-07-0460
ISSN
0340-6245
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Administration, OralAdultAgedArthroplasty, Replacement, KneeCanadaDose-Response Relationship, DrugElective Surgical ProceduresEnoxaparinFactor Xa InhibitorsFemaleFibrinolytic AgentsHemorrhageHumansInjections, SubcutaneousMaleMiddle AgedPulmonary EmbolismThrombinThromboembolismTime FactorsTreatment OutcomeUnited StatesVenous Thrombosis